Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Biotech
Novo taps Photys for multi-molecule cardiometabolic collab
Novo Nordisk will pay Photys up to $186 million to help develop proximity-based therapeutics for an unnamed cardiometabolic disease target.
Fraiser Kansteiner
Dec 18, 2024 7:30am
Roche culls ph. 3 Spark gene therapy in hemophilia
Dec 16, 2024 12:24pm
Pyxis' shares fall on lukewarm early ADC results in solid tumors
Nov 21, 2024 2:30pm
AbbVie sues BeiGene over blood cancer drug trade secrets
Sep 11, 2024 10:17am
The Fierce 50 of 2024
Sep 9, 2024 5:00am
Big Pharma ROI for drug R&D saw surprise rebound in 2023: report
Apr 25, 2024 12:01am
